We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients.
- Authors
Terveer, Elisabeth M; Gool, Tom van; Ooijevaar, Rogier E; Sanders, Ingrid M J G; Boeije-Koppenol, Eline; Keller, Josbert J; Bart, Aldert; Kuijper, Ed J; Group, Netherlands Donor Feces Bank (NDFB) Study
- Abstract
Background Patients with multiple recurrent Clostridioides difficile infections (rCDI) are treated with fecal microbiota transplantation (FMT), using feces provided by healthy donors. Blastocystis colonization of donors is considered an exclusion criterion, whereas its pathogenicity is still under debate. Methods The introduction of molecular screening for Blastocystis sp. at our stool bank identified 2 donors with prior negative microscopies but positive polymerase chain reactions (PCRs). Potential transmission of Blastocystis sp. to patients was assessed on 16 fecal patient samples, pre- and post-FMT, by PCR and subtype (ST) analyses. In addition, clinical outcomes for the treatment of rCDI (n = 31), as well as the development of gastrointestinal symptoms, were assessed. Results There was 1 donor who carried Blastocystis ST1, and the other contained ST3. All patients tested negative for Blastocystis prior to FMT. With a median diagnosis at 20.5 days after FMT, 8 of 16 (50%) patients developed intestinal colonization with Blastocystis , with identical ST sequences as their respective donors. Blastocystis -containing fecal suspensions were used to treat 31 rCDI patients, with an FMT success rate of 84%. This success rate was not statistically different from patients transferred with Blastocystis sp.–negative donor feces (93%, 76/82). Patients transferred with Blastocystis sp.–positive donor feces did not report any significant differences in bowel complaints in the first week, after 3 weeks, or in the months following FMT. Conclusions We demonstrated the first transmission of Blastocystis ST1 and ST3 from donors to patients by FMT. This did not result in gastrointestinal symptomatology or have any significant effect on rCDI treatment outcomes.
- Subjects
FECAL analysis; TRANSMISSION of protozoan diseases; GASTROINTESTINAL diseases; MICROSCOPY; POLYMERASE chain reaction; TRANSPLANTATION of organs, tissues, etc.; FECAL microbiota transplantation; DESCRIPTIVE statistics; DISEASE risk factors
- Publication
Clinical Infectious Diseases, 2020, Vol 71, Issue 10, p2630
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciz1122